May 3, 2004 |
A study of the practices of 19 Philadelphia-area cancer surgeons suggests that many breast cancer patients receive treatment that is inadequate, inappropriate or too aggressive. The study, led by Bernard Bloom, a research professor of medicine at the University of Pennsylvania, looked at whether the surgeries and postoperative care of 464 breast cancer patients were in line with expert guidelines or the best research. "Most women with breast cancer in this study were not treated according to regimens from either" the guidelines or research, concluded the study, published earlier this year in the British Journal of Cancer.
October 21, 2003 |
South Jersey cancer patients who crossed the river for treatment at Philadelphia hospitals will now have the option of getting the latest care at the Cancer Institute of New Jersey at Cooper University Hospital in Voorhees. Gov. McGreevey said yesterday that the state would provide $5 million to develop the partnership between Cooper and the New Brunswick-based Cancer Institute of New Jersey, one of 39 facilities nationwide affiliated with the National Cancer Institute. Other National Cancer Institute affiliates, providing comprehensive cancer treatment, include the Abramson Cancer Center of the University of Pennsylvania, the Fox Chase Cancer Center, and the Kimmel Cancer Center at Thomas Jefferson University.
August 30, 2011 |
BEFORE SHE got sick, Hannah Max was many things: stellar math and biology student, passionate horse rider, lover of sushi. Since her diagnosis with Stage IV, high-risk neuroblastoma - a rare and deadly childhood cancer that attacks the nervous system - the 13-year-old is now a medical trailblazer, too. And you, Daily News readers, are partially responsible for that. So thank you for what you've done, not just for Hannah but for other children in desperate need of cancer care in Philadelphia.
December 15, 2011 |
Fox Chase Cancer Center will become part of the Temple University Health System, officials announced Thursday. The combination, which is expected to close next summer, will join two prominent Philadelphia health-care institutions, both of which have faced fiscal difficulties lately. Temple, based in North Philadelphia, will get a nationally recognized research partner that could help it compete with other academic medical centers in the region. Fox Chase, which will keep its name, will get a bigger referral base for patients, room to expand at Temple's Jeanes Hospital next door, and a chance to save money as health-care reform further squeezes the dollars available for clinical care and research.
October 4, 2012 |
Revenue growth at area health systems was uneven in the fiscal year ended June 30, with the biggest systems showing strong gains while smaller competitors scraped out, at best, meager increases. Revenues from patients at Holy Redeemer Health System in Meadowbrook, for example, have been nearly flat since 2009. They were $336 million in the year ended June 30. That was $2 million more than in 2009 and $3.5 million less than in 2011. At Montgomery County neighbor Abington Health, patient revenues have been stuck at about $760 million for three years in a row, reflecting a widespread challenge that hospital executives attribute to changing medical-treatment methods and the weak economy.
October 25, 2014 |
While there is much hopeful news these days on the cancer treatment front, a new report finds that many patients are suffering from unmet financial, emotional, and physical needs. Many struggle with serious anxiety, fatigue, and difficulty working, according to the Cancer Support Community report. As they live longer, patients say they need more help coping with long-term side effects. A significant portion have skimped on medical care and many have cut spending on food to save money.
February 5, 2013 |
Embracing the promise of personalized medicine, Fox Chase Cancer Center is offering a high-tech DNA test that can identify the genetic mutations driving an individual patient's cancer. Other leading medical centers and biotech firms are launching similar tests, which should help doctors make cancer care more effective and less toxic. Experts say this customized approach will become increasingly important as the arsenal of drugs that target cancer genes grows. For patients at the forefront, however, the value of cutting-edge DNA testing is hard to predict.
February 3, 2009 |
Between May 2006 and March 2007, Cheryl Bayard's life was all about fighting her breast cancer. There was surgery, radiation and chemotherapy to endure. She saw doctors and nurses constantly. Then it was over. Except that it wasn't. "All of a sudden, they say, 'That's it,' " said Bayard, a retired art teacher who lives near Tylersport in Montgomery County. "You're left with, Now what?" Bayard was on her own to piece together information about her future medical needs from fellow survivors, guest speakers at support groups and her doctors.
December 7, 2011 |
SAN ANTONIO - New research casts doubt on a popular treatment for breast cancer: a week of radiation to part of the breast instead of longer treatment to all of it. Women who were given partial radiation were twice as likely to need their breasts removed later because the cancer came back, doctors found. The treatment uses radioactive pellets briefly placed in the breast instead of radiation beamed from a machine. At least 13 percent of older patients in the United States get this now, and it is popular with working women.
December 27, 2010 |
For many cancer patients, the main obstacle to getting treatment in Philadelphia is not health insurance, side effects, or lack of therapies. "Twenty percent of appointments are canceled because patients can't get there," said Gerald Furgione. As executive director of Phillycarshare, Furgione has figured out a way to help: Enlist volunteers to drive cancer patients to treatment in car-share vehicles, at no cost to the drivers or riders. The Phillypatientride program, believed to be unique in the United States, will hit the road Jan. 4. Reduced car-share fees will be covered by the American Cancer Society, Hahnemann University Hospital, and Temple University Hospital.